Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies
Open accessThe DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Abstract
Over the last decade, there has been a growing appreciation of the importance of identifying and treating cognitive impairment associated with bipolar disorder, since it persists in remission periods. Evidence indicates that neurocognitive dysfunction may significantly influence patients' psychosocial outcomes. An ever-increasing body of research seeks to achieve a better understanding of potential moderators contributing to cognitive impairment in bipolar disorder in order to develop prevention strategies and effective treatments. This review provides an overview of the available data from studies examining treatments for cognitive dysfunction in bipolar disorder as well as potential novel treatments, from both pharmacological and psychological perspectives. All these data encourage the development of further studies to find effective strategies to prevent and treat cognitive impairment associated with bipolar disorder. These efforts may ultimately lead to an improvement of psychosocial functioning in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Coupled with the results of other small studies involving other interventions, these findings suggest that there is considerable hope in addressing cognitive and functional deficits in BD.118”
From Canadian Network for Mood and Anxiety Treatments ( CANMAT ) and International Society for Bipolar Disorders ( ISBD ) 2018 guidelines for the management of patients with bipolar disorder (2018) · cites this paper as [118]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883 · cited 2×
“Taking into account the scarcity of adequately powered randomized trials and discrepant results on research in this field, it will be highly recommendable to conduct further studies investigating treatments targeting cognition in bipolar patients following the Consolidated Standards for Reporting Trials (Moher et al.,…”
BackgroundYatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
Stern, Y. (2009) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2009.03.004 · Cited by 2,943
Lichtenstein, P., Yip, B. H., Björk, C., Pawitan, Y., Cannon, T. D., Sullivan, P. F., & Hultman, C. M. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60072-6 · Cited by 2,125
Grande, I., Berk, M., Birmaher, B., & Vieta, E. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00241-x · Cited by 1,710
Self-citationCuthbert, B. N. (2014) · World Psychiatry · doi:10.1002/wps.20087 · Cited by 1,377 · cited 1×
“This framework incorporates genetics, neuroimaging, and cognitive sciences for a new classification of mental disorders (Cuthbert, 2014), where the cognitive system is among the proposed higher order domains.”
MethodBora, E., Yucel, M., & Pantelis, C. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.009 · Cited by 1,022 · cited 1×
“In this sense, some authors have suggested that neurocognitive deficits could be considered as putative endophenotypes of BD (Arts et al., 2008; Balanzá-Martínez et al., 2008; Bora et al., 2009).”
BackgroundA meta-analysis of cognitive deficits in euthymic patients with bipolar disorder
Robinson, L. J., Thompson, J. M., Gallagher, P., Goswami, U., Young, A. H., Ferrier, I. N., & Moore, P. B. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.02.016 · Cited by 962 · cited 1×
“Data from different meta-analyses confirm that most patients with bipolar disorder show neurocognitive dysfunction, even during euthymia (Robinson et al., 2006; Bourne et al., 2013; Bortolato et al., 2015).”
Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives
Arts, B., Jabben, N., Krabbendam, L., & van Os, J. (2008) · Psychological Medicine · doi:10.1017/s0033291707001675 · Cited by 707 · cited 1×
“In this sense, some authors have suggested that neurocognitive deficits could be considered as putative endophenotypes of BD (Arts et al., 2008; Balanzá-Martínez et al., 2008; Bora et al., 2009).”
BackgroundBourne, C., Aydemir, Ö., Balanzá‐Martínez, V., Bora, E., Brissos, S., Cavanagh, J. T. O., Clark, L., Cubukcuoglu, Z., Dias, V. V., Dittmann, S., et al. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12133 · Cited by 644
Self-citation
Cited by
Items 201–299 of 299
Liu, S., Jia, Y., Liu, X., Ma, R., Zheng, S., Zhu, H., Yin, M., & Jia, H. (2023) · Acta Psychologica · doi:10.1016/j.actpsy.2023.103903 · Cited by 1
Tang, C., Huang, W., Tan, Y., Liu, Y., Zheng, G.-E., Li, B., Chen, W., Yu, Y. W., Xu, G., Li, X., et al. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-05897-8 · Cited by 3
“Although cognitive dysfunctions are present throughout all illness phases, they are more pronounced during acute episodes in euthymic BD II patients [8].”
BackgroundInfluentialMaihofer, E., Sachs, G., & Erfurth, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13164843 · Cited by 2
Jiang, H., Ren, B., Zhang, Y., Zhou, Y., Wu, J., Yu, X., Yu, H., Ni, P., Xu, Y., Deng, W., et al. (2025) · Psychological Medicine · doi:10.1017/s0033291725000741 · Cited by 1
“It is worth noting that cognitive disturbances are pervasive among BD patients, persisting even during intervals devoid of manic or depressive episodes (Lima, Peckham, & Johnson, 2018; Solé et al., 2017).”
İnce, E., Ozkutuk, G. K., Cagal, S., Öztürk, E. Ö., Elik, T., Akdas, N., Horasan, C., Çakır, S., Direk, N., & Aydemır, Ö. (2025) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.70037 · Cited by 1
Sex differences in cognitive function among patients with bipolar disorder
Wang, Z., Zhang, G., Song, H., Yang, Z., Wei, C., & Cao, Y. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1639276 · Cited by 1
Role of glymphatic system function in cognitive dysfunction among patients with bipolar disorder
Chen, M., Liou, Y., Hsu, J.-W., Tsai, S., Chang, C., & Bai, Y. (2026) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf069 · Cited by 2
Yamasaki, F., Nakata, Y., Kanahara, N., Miyazawa, A., Mashimo, Y., Hirose, Y., Oda, Y., Niitsu, T., Onouchi, Y., & Iyo, M. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03149-5 · Cited by 1
“How - ever, cognitive impairments are commonly observed in multiple psychiatric disorders (Solé et al. 2017; Pan et al. 2019), whereas autistic traits are relatively characteristic of ASD and schizophrenia in clinical settings.”
Hamada, F., Gotoh, L., Tomiyama, Y., Sugawara, H., Ogata, M., Kumagai, H., Asada, R., Hatae, R., Yasumatsu, K., & Hori, H. (2026) · Metabolites · doi:10.3390/metabo16050328 · Cited by 1
Does neurodevelopmental load predict cognitive flexibility?
Carpentier, A., Durand, A., Naassïla, M., Lecardeur, L., & Bralet, M. (2026) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2026.100446 · Cited by 1
Prefrontal spine loss in neuropsychiatric disorders: circuit consequences for cognition
Bitzenhofer, S. H., & Günther, A. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1730869 · Cited by 1
“Impairments in attention and executive functions have been re-ported in the majority of BPD patients and persist even during euthymic phases (74).”
Tang, H. D., Lin, S., Liu, X., Chen, J., & Zuo, X. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1863310 · Cited by 1
“These de fi cits may further affect daily living, occupational functioning, and social adaptation, thereby becoming important determinants of psychosocial recovery and long-term prognosis (12 – 14).”
Pacheco, A. E., Enes, C. D. L., Clementino, M. T. R., Belo, V. S., Duarte, S. J. H., & Machado, R. M. (2020) · Enfermagem em Foco · doi:10.21675/2357-707x.2020.v11.n3.2881 · Cited by 4
Wu, Y., & Yin, S. (2021) · Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research · doi:10.2991/assehr.k.211020.317 · Cited by 1
Cognitive Impairments in Patients with Bipolar Affective Disorder in Remission
Chumakov, E. M., Петрова, Н. Н., Васильевич, Л. О., & Ashenbrenner, Y. V. (2022) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-022-01206-6 · Cited by 1
“Points Part 2 13 [12; 14] 14 [11; 14] U = 608.”
BackgroundSylvia, L. G., Tovey, R. E., Katz, D., Boccagno, C. E., Stromberg, A. R., Peters, A. T., Temes, C. M., Gold, A. K., Mow, J. L., Puvanich, N., et al. (2023) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000703 · Cited by 3
Estudillo‐Guerra, M. A., Linnman, C., Gálvez, V., Chapa-Koloffon, G., Pacheco‐Barrios, K., Morales-Quezada, L., & Ramos, M. F. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1244134 · Cited by 1
Zheng, X., Zhang, X., Zhang, Y., Chen, C., & Ji, E. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1392437 · Cited by 1
Chen, B.-F., Liu, L., Lin, F.-C., Zeng, H.-M., Huang, H., Zhang, C., Liu, C., Chen, X., Peng, J., Wang, Y.-F., et al. (2024) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i1.100685 · Cited by 1
Mekuriaw, B. Y., Wondmu, H., Asfaw, M., Kassaw, C., & Molla, A. (2025) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-025-02932-1 · Cited by 2
Bipolar Affective Disorder in Men
Young, A. H., & Hidalgo‐Mazzei, D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108646765.015 · Cited by 1
Shen, Y., Kong, L., Lai, J., & Hu, S. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04820-x · Cited by 2
“BD poses a severe burden to the public health system, and causes dysfunction in attention, memory, and executive functions, in a majority of patients [8].”
BackgroundWang, X., & Lu, X. (2024) · Research Square · doi:10.21203/rs.3.rs-4341528/v1 · Cited by 1
La reserva cognitiva en el trastorno mental grave
Amoretti, S. (2019) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Structure of cognitive disorders in patients with primary episode of bipolar affective disorder
Mysula, Y., & Venger, O. (2020) · Romanian Journal of Medical Practice · doi:10.37897/rjmp.2020.1.13 · Cited by 1
Chen, W.-Y., Chen, J.-C., Cheng, Y., Liu, H., Kuo, P., & Huang, M. (2020) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_2_20
Shin, H., Choi, J. H., So, H., Choi, H., Park, Y. C., Tan, C. H., Lin, S., Shinfuku, N., Park, S., & Kim, K. (2020) · 신경정신의학 · doi:10.4306/jknpa.2020.59.3.277
Mysula, Y. (2019) · Medicine Today and Tomorrow · doi:10.35339/msz.2019.85.04.13
Characteristics of verbal fluency in patients with a primary episode of bipolar affective disorder
Mysula, Y. (2020) · Psychiatry Neurology and Medical Psychology · doi:10.26565/2312-5675-2020-13-02
“Розлади когнітивної функції розглядаються як важлива складова комплексних психопатологічних змін при БАР, вони виявляються як в маніакальній і депресивній фазі, так і в період інтермісії [10-12].”
Chen, W., Huang, M., Lee, Y., Chang, C.-E., Lin, S., Chiu, C., Liu, H., Kuo, C., Chen, P., & Kuo, P. (2020) · doi:10.21203/rs.3.rs-97680/v1
“Such longitudinal cognitive pro les can potentially facilitate further genetic and biological studies and help clinicians develop more effective intervention strategies (Solé et al. 2017).”
BackgroundCai, S., Zhou, L., Yang, X. F., Ma, C., Xu, L., & Qian, R. (2021) · Journal of Nanomaterials · doi:10.1155/2021/9993172 · Cited by 1
“Because bipolar disorder can damage the cognitive function and social function of patients, it will not only affect the patient’s own quality of life but also bring a heavy burden to their family and society [6, 7].”
BackgroundC., M., Ö., S., C., G., M., P., S., B., F, G., J., W., M., K. T., N, M., D., B., et al. (2021) · bioRxiv · doi:10.1101/2021.06.09.447782 · Cited by 3
“18 Cognitive impairments, especially related to working memory and executive functioning, are among the core symptoms of BD in addition to mood disturbances (1).”
BackgroundMardani, A. P., Hassanvandi, S., Dadashi, M., Zolghadriha, A., Javadani, H., & Mousavi, S. E. (2021) · Research Square · doi:10.21203/rs.3.rs-519087/v1
Cahn, A. J. (2021) · cIRcle (University of British Columbia) · doi:10.14288/1.0400204
Schizophrenie und bipolare Störung: Behandlung kognitiver Beeinträchtigungen
Riedel, P., Smolka, M. N., & Bauer, M. (2018) · Der Nervenarzt
Ralat, S. I., Alicea-Cuprill, G., Arroyo, Y., & Otero, W. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245890
“Additionally, the literature maintains that patients with BD show cognitive impairment that persists in remission periods and significantly influences those patients’ psychosocial outcomes, with a large degree of heterogeneity among them [29].”
BackgroundFactors affecting cognitive functioning in individuals with bipolar disorder in euthymic phase
Benjamin, M., Kallivayalil, R. A., & undefined, K. (2021) · Kerala Journal of Psychiatry · doi:10.30834/kjp.34.2.2022.287
Pollak, J. M. (2022) · Psychiatric Annals · doi:10.3928/00485713-20220124-01
Structural brain abnormalities in bipolar disorder
Bellani, M., Zovetti, N., Sanches, M., Matsuo, K., Soares, J. C., & Brambilla, P. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197574522.003.0002
Clinical Staging of Psychiatric Disorders: Its Utility in Mental Health Prevention
Rutigliano, G., & Grande, C. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-97906-5_2
Attitude to Body-Risk Factor or Health Factor in Psychopathology
Izydorczyk, B., Enea, V., Lipowski, M., & Sitnik‐Warchulska, K. (2022) · Frontiers research topics · doi:10.3389/978-2-88976-289-7
THE EFECTS OF COGNITIVE REMEDIATION THERAPY IN BIPOLAR DISORDER PATIENTS
Astami, C. (2022) · Journal of Psychiatry Psychology and Behavioral Research · doi:10.21776/ub.jppbr.2022.003.02.9
“Promoting a healthy lifestyle, and doing aerobic exercise to prevent overweight or obesity are also crucial.(22)”
BackgroundInfluentialNeurostructural and neurocognitive correlates of APOE ε4 in youth bipolar disorder
Puramat, P., Dimick, M. K., Kennedy, K. G., Zai, C. C. H., Kennedy, J. L., MacIntosh, B. J., & Goldstein, B. I. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811221147151 · Cited by 1
“…adults with BD, youth with BD exhibit neurocognitive deficits in various domains including emotion processing and executive function (verbal and non-verbal memory, working memory, sustained attention, problem solving, and processing speed) (Elias et al., 2017; Lima et al., 2018; Solé et al., 2017).”
BackgroundMethodRakitzi, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-27837-2_18
Rakitzi, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-27837-2_17
ВИКОРИСТАННЯ ФІТОТЕРАПІЇ В ЛІКУВАННІ ПСИХІЧНИХ ЗАХВОРЮВАНЬ НА ПРИКЛАДІ БІПОЛЯРНОГО РОЗЛАДУ
Тюпова, Т., Ткаченко, Г. М., & Kurhalyuk, N. (2023) · Biota Human Technology · doi:10.58407/bht.1.23.6
Neurodegenerative Processes in Bipolar Disorder
Nasser, R. V., Penido, A. L. R., Filho, D. G. N., & Duailibi, K. (2023) · International Journal of Health Science · doi:10.22533/at.ed.1593582310082
Puzhakkal, J. C., Thomas, S. P., Kallivayalil, R. A., Aravindakshan, R., Geo, J., MOHAMMED, F. A., Thomas, S., SUSEELAN, A., & DAVID, T. (2023) · Minerva Psychiatry · doi:10.23736/s2724-6612.21.02284-3
de Santiago-Díaz, A. I., Pérez-Poo, T., Pindado-Jiménez, E., Cortez-Astudillo, G., Zabala-Alonso, A., & Gómez-Ruíz, E. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00051
Alterations of plasma neuron-derived exosomal microRNAs in patients with bipolar disorderPreprint
Li, T., Qi, X., Jiang, H., Ren, B., Zhang, Y., Zhou, Y., Wu, J., Yu, X., Ni, P., Xu, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3530567/v1
Sanchidrián, D. C., de Dios-Perrino, C., Bayón, C., Vega, B. R., Bravo‐Ortiz, M. F., Ortega, M. A., González-Pinto, A., & Lahera, G. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1279342 · Cited by 3
Prises en charge de la symptomatologie cognitive dans les troubles bipolaires
Isaac, C., Joanny, S., Bouaziz, N., Castillo, M.-C., & Januel, D. (2024) · L Évolution Psychiatrique · doi:10.1016/j.evopsy.2024.01.004 · Cited by 2
Dutra, P. E. P., Quagliato, L. A., Curupaná, F. T., Peres, L. Z., Pacini, V. L., da Silva, C. R. M., Garcia, J. S., Campillo, B., & Nardi, A. E. (2024) · Clinics · doi:10.1016/j.clinsp.2024.100328
Die Arbeitsgedächtniskapazität bei Patienten mit bipolarer affektiver Störung
Lehmann, T. (2024) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.84441
Durán, E. T., Jiménez-Rodríguez, L. I., Castañeda-Franco, M., Jiménez‐Tirado, M., Twamley, E. W., Fresán, A., & Yoldi‐Negrete, M. (2024) · Evaluation & the Health Professions · doi:10.1177/01632787241253021
“Such information could guide the choice of cognitive remediation approaches based on the true needs of patients (Sol´e et al., 2017).”
The Management of Neurocognitive Impairment in Mood Disorders
Gallagher, P., & Young, A. H. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108973922.023 · Cited by 1
Charfi, N., Bouaziz, A., Omri, S., Gassara, I., Feki, R. C., Smaoui, N., Zouari, L., Maalej, M. A., Thabet, J. B., & Maalej, M. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241253631
“10,11 Pour ce qui est du trai-tement, la plupart des médicaments utilisés pour traiter le TBP semblent avoir un potentiel à aggraver les altérations cognitives en rapport avec la maladie.”
Treatment-Resistant Bipolar Disorder
Rakitzi, S., & Georgila, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-59001-6_3
Mena, J. I., Ilzarbe, D., Moya, M., Camprodon‐Boadas, P., Sugranyes, G., de la Serna, E., & Baeza, I. (2024) · Revista de Psiquiatría Infanto-Juvenil · doi:10.31766/revpsij.v41n3a4
Mindfulness-Based Therapies with Bipolar Disorder
Russell, T. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-63349-2_13 · Cited by 1
Sex differences in inflammatory markers in bipolar disorder
Liu, Y., Ng, H. X., Sutherland, A. N., Joe, S., Soontornniyomkij, B., Klaus, F., & Eyler, L. T. (2025) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2025.100892
Köse, S., & Hocaoğlu, Ç. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06908-y · Cited by 1
“Studies conducted with patients diagnosed with BD who were not taking medication have shown that cognitive impairment is due to the effects of the disease, and very little of the effect is due to the medication itself [61].”
La période de rémission chez les patients bipolaires
Duranté, E. K., & Henry, C. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77180-4.00010-x
Li, X., Liu, L., He, G., Zhao, J., Chen, J., Tang, S., Chen, R., Zhong, S., & Jia, Y. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120439 · Cited by 1
Li, D., Tsai, S., Bai, Y., Su, T., Chen, T., Chen, M., & Liang, C. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120560
Bastelica, T., Carré, A., Lespine, L., Boukouaci, W., Wu, C., Pelletier, A., Étain, B., Bellivier, F., Aouizerate, B., Martinez, P., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106164 · Cited by 1
Kulkarni, N. P., Zai, C. C. H., Dimick, M. K., Sultan, A. A., Young, L. T., & Goldstein, B. I. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120926
Cui, X., Xue, T., Zhang, Z., Yang, H., & Ren, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26708741
Hsueh, Y.-Z., Huang, C.-Y., Kuo, P.-H., Cheng, Y., Huang, M.-C., Chiu, C. C., Kuo, C.-J., Chen, P.-Y., & Chen, W.-Y. (2024) · Figshare · doi:10.6084/m9.figshare.25708969
Zou, T., Yang, M., Chen, Z., Xie, H., Huang, J., Qin, Y., Liu, F., Chen, H., Xu, X., Chen, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25876093
Chen, Z., Zhang, Z., Li, F., Zhao, L., 薄奇静, Zhou, Y., & Wang, C. (2024) · Figshare · doi:10.6084/m9.figshare.26682757
Schandorff, J. M., Eggers, M. B., Zarp, J., Nordseth, B. O. B., Hansen, L., Kessing, L. V., & Miskowiak, K. W. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.121038
Delvecchio, G., Videtta, G., Serpente, M., Squarcina, L., Pansitta, C., Fenoglio, C., Consoli, L. D., Ferro, A., Callari, A., Prunas, C., et al. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03449-y · Cited by 1
“These episodes affect patients ’ daily functioning, interpersonal relationships, and general well-being causing debilitating cognitive and behavioral impairments [2].”
Kartha, A., Shoib, S., Zaidi, I., Das, S., Punnoose, V. P., Saeed, F., & Sumesh, T. P. (2026) · Future Health · doi:10.25259/fh_84_2025
Ruan, Z., & Zhu, J. (2026) · Brain and Behavior · doi:10.1002/brb3.71274
Smrynis, A., Smyrnis, G., Lazaridi, M., Mantas, A., Karantinos, T., Klein, C., Maragos, P., & Smyrnis, N. (2026) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2026.100426
Sun, G., Zhuang, T., Wang, M., & Zhang, X. (2026) · ALPHA PSYCHIATRY · doi:10.31083/ap42381
“Such cognitive impairments may exacerbate the risk of affective symptom relapse, as diminished cognitive function increases life stressors and interpersonal difficulties [34].”
The association between psychotropic medications and cognitive functioning in bipolar disorder
Dickerson, F., Origoni, A. E., Katsafanas, E., Rowe, K. C., Khan, S., Calahatian, A. T., Mukhtar, F., & Yolken, R. (2026) · International Journal of Bipolar Disorders · doi:10.1186/s40345-026-00413-1 · Cited by 1
“Among persons with bipolar disorder, there is wide variability in cognitive functioning which cannot be fully explained by clinical subtype or symptom severity (Keramatian et al. 2021; Solé et al. 2017; Flaaten et al. 2024).”
Isaac, C. (2018) · theses.fr (ABES) · doi:10.70675/76f0e456zbbffz46edzad9bza7fe3f88440a · Cited by 4
Mapping the Central Genes in Bipolar Disorder Pathways: From Data to Diagnosis
Seidkhani, H., & Yaghoubi, S. (2026) · Archives of Neuroscience · doi:10.5812/ans-169584
“One of these ways is to conduct bioinformatics studies (26, 27).”
Zhang, X., Wang, X., Zhu, H., Yu, H., Fu, L., Shu, W., Ye, X., Lim, Z., Saeed, S., Nguyen, H. L., et al. (2026) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2026.101467
Shan, Z., Zhu, Q., Wang, S., Xia, Y., Yang, Y., & Tian, L. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117155
Kong, L., Yang, Y., Zhou, W., & Hu, S. (2026) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2500307
Wang, Z., Li, X., Song, H., Wei, C., Gao, L., Jiang, Z., Wang, Z., Du, J., Zhang, W., & Li, K. (2026) · Behavioral Psychology/Psicología Conductual · doi:10.31083/bp44839
Wang, X., Zhang, J., Wu, F., Shen, L., Wang, L., Wu, H., Xiao, Q., Yi, X., Liu, X., Grecucci, A., et al. (2026) · NeuroImage Clinical · doi:10.1016/j.nicl.2026.104005
“In our study, we used cognitive tests that reflected the primary neurocognitive deficits in patients with BD, including attention, memory, and executive function (Sol ´ e, 2017).”
Deng, J., Ma, Y., Zhou, L., Zhang, S., & Ao, Z. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08065-2
“In addition, Sole suggests that improvements in mood and anxiety symptoms from exercise may further promote cognitive functioning [22].”
Banu, M. F., Bharadwaj, B., & Raghavan, B. (2026) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry_836_25
Fares‐Otero, N. E., Solé, B., Jespersen, A. E., Roberto, N., Martin‐Parra, S., López-Escribano, R., Pérez‐Ramos, A., Piazza, F., Ruíz, A., Varo, C., et al. (2026) · Bipolar Disorders · doi:10.1111/bdi.70118
“This is consistent with reports of significant cognitive impairments in individuals with BD [3, 6, 47] but also indicates that these difficulties are likely to be detected in a VR environment like CAVIR that directly targets cognitive skills in a simulated daily-life situation (e.g., preparing a…”
Self-citationMirzazadeh, H., Sadeghi, E., Mostafavi, S., Elmi, S., Moshfeghinia, R., & Rahimi, S. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122309
Hayasaka, T., Nagashima, I., Hoshino, M., Teruya, K., Matumoto, Y., Murao, M., Maruki, T., Watanabe, M., Katagiri, T., Kurihara, M., et al. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1844682
Phillips, W. T., & Schwartz, J. G. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1897376
“…are associated with structural brain changes, such as reduced cortical thickness in prefrontal areas, and are increased by the number of past mood episodes (Sole et al., 2017). managing stress, and adjusting medications with a doctor are critical management strategies (Marchetti et al., 2025).”
Hamada, F., Hori, H., Kumagai, H., Ogata, M., Yokoyama, H., Tomiyama, Y., Sugawara, H., Asada, R., Hatanaka, A., Masuda, M., et al. (2026) · Metabolites · doi:10.3390/metabo16090679
Belizário, G. O., Espíndola, F. M. D. M., Duarte, C. C., Ferreira, Y. R., Pinto, S. R., Amaral, T., Keller, N. G., & Lafer, B. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122591
Kulkarni, N. P., Zai, C. C. H., Dimick, M. K., Sultan, A. A., Andreazza, A. C., Gonçalves, V. F., Young, L. T., & Goldstein, B. I. (2026) · Research Square · doi:10.21203/rs.3.rs-11155938/v1
Metadata
- Authors
- Solé, B., Jiménez, E., Torrent, C., Reinares, M., Bonnin, C. D. M., Torres, I., Varo, C., Grande, I., Valls, E., Salagre, E., Sanchez-Moreno, J., Martinez-Aran, A., Carvalho, A. F., & Vieta, E.
- Affiliations
- Universidade Federal do Ceará (BR)
- Corresponding author
- Vieta, Eduard
- ORCID
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-05-11
- Volume
- 20
- Issue
- 8
- Pages
- 670-680
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC5570032
- OpenAlex
- W2613431376
- Cited by
- 299
- References
- 125
- Citations by year
- 2026: 30 · 2025: 35 · 2024: 48 · 2023: 28 · 2022: 40 · 2021: 37 · 2020: 34 · 2019: 24 · 2018: 21 · 2017: 1
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- Generalitat de Catalunya (2014_ SGR_398)
- Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya
- Ministerio de Economía y Competitividad (PI12/00912, PI12/, CPI14/00175)
- Centro de Investigación Biomédica en Red de Salud Mental
- Instituto de Salud Carlos III (PI11/, CPI14/00175, 00012, PI15/00330, JR15/00012, 2008-2011)
- European Regional Development Fund
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- bipolar disorder, cognitive impairment, neurocognitive impairment, cognitive impairment prevention, pharmacotherapy, psychological intervention, psychosocial functioning
- MeSH terms
- Bipolar Disorder, Humans, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
